急性缺血性卒中血管内治疗后成功再通患者的缺血后适应:一项先导随机对照试验
结果显示缺血后适应组48小时梗死增长低于对照组(中位差-8.7 mL,95%CI -17.1至-1.4,P=0.015),但90天改良Rankin量表分布无显著差异。
要点
- 血管内治疗后成功再通患者行缺血后适应可减少48小时梗死增长。
- 缺血后适应组24小时NIHSS评分低于对照组(中位差-3.0)。
- 90天改良Rankin量表分布两组无显著差异。
核心结论
- 在急性大血管闭塞性缺血性卒中患者中,成功再通后行缺血后适应可减少梗死增长,但需更大规模随机试验确认。
主要发现
- 缺血后适应组48小时MRI梗死增长低于对照组,中位差-8.7 mL(95%CI -17.1至-1.4,P=0.015)。
- 在系列MRI亚组(n=30,每组15例)中,缺血后适应组早期梗死增长更低,中位差-3.2 mL(95%CI -8.7至-0.1,P=0.045)。
- 缺血后适应组24小时NIHSS评分低于对照组,中位差-3.0(95%CI -5.0至-1.0,P=0.005)。
- 90天改良Rankin量表分布两组无显著差异,共同比值比1.1(95%CI 0.4-2.6,P=0.921)。
关键数值与推荐
- 缺血后适应方案为4个循环的2分钟球囊充盈后2分钟放气,球囊置于原颅内动脉闭塞部位。
临床怎么用
- 对于血管内取栓成功再通的急性缺血性卒中患者,缺血后适应可能作为辅助治疗减少梗死增长,但当前证据尚不足以改变常规实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ischemia-reperfusion injury contributes to continued infarct growth despite successful recanalization. Ischemic postconditioning (IPostC) reduces infarct size in preclinical models, but its therapeutic effect as an adjunct to endovascular thrombectomy remains uncertain. We investigated whether IPostC performed after successful recanalization reduces infarct growth in patients with acute ischemic stroke. METHODS: This single-center, prospective, randomized, open-label trial with blinded end point assessment was conducted at Tianjin Huanhu Hospital between September 2024 and May 2025. Patients with acute ischemic stroke who underwent endovascular thrombectomy within 24 hours of symptom onset or last known well, had a baseline National Institutes of Health Stroke Scale score ≥6 and a prestroke modified Rankin Scale score ≤2, and achieved successful recanalization after endovascular thrombectomy were randomly assigned to the IPostC or control group. IPostC consisted of 4 cycles of 2-minute balloon inflation followed by 2-minute deflation, with the balloon positioned at the original intracranial arterial occlusion site. The primary outcome was infarct growth from baseline to 48-hour magnetic resonance imaging (MRI). Secondary outcomes included infarct volume on immediate postprocedure MRI (within 2 hours) and on 48-hour MRI; early infarct growth and late infarct growth; serial National Institutes of Health Stroke Scale scores during hospitalization; and modified Rankin Scale score at 90 days. Primary and secondary outcomes were analyzed in the intention-to-treat population using unadjusted between-group comparisons. RESULTS: Sixty patients were enrolled, with 30 randomly assigned to each group. Infarct growth from baseline to 48-hour MRI was lower with IPostC than with control (median difference, -8.7 mL [95% CI, -17.1 to -1.4]; P=0.015). In the serial MRI subgroup (n=30; 15 per group), early infarct growth was also lower with IPostC (median difference, -3.2 mL [95% CI, -8.7 to -0.1]; P=0.045). Patients in the IPostC group had a lower National Institutes of Health Stroke Scale score at 24 hours (median difference, -3.0 [95% CI, -5.0 to -1.0]; P=0.005). The 90-day modified Rankin Scale distribution did not differ significantly between groups (common odds ratio, 1.1 [95% CI, 0.4-2.6]; P=0.921). CONCLUSIONS: In this pilot randomized trial, IPostC performed after successful recanalization reduced infarct growth in patients with acute ischemic stroke due to large-vessel occlusion. These findings require confirmation in larger randomized trials. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT06545734.
引用
- Xu Y, Zhang B, Liu S, et al. Ischemic Postconditioning in Patients With Acute Stroke With Successful Recanalization After Endovascular Therapy: A Pilot Randomized Controlled Trial. Stroke. 2026. PMID: 42460477. doi:10.1161/STROKEAHA.125.056167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。